This is in contrast to the previously reported role of MENA as a tumorigenesis-promoting protein – MENA is overexpressed in ∼75% of primary breast cancers and has a role in activation of MAPK and Akt signalling [41], [42]. This evidence concerns the gene EGFR and breast carcinoma.